Related Experiment Video

Updated: Jul 15, 2026

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
07:43

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

Published on: September 28, 2016

[New aspects of the pathophysiology of pneumonia]

S Hippenstiel1, M Witzenrath, B Opitz

  • 1Medizinische Klinik mit Schwerpunkt Infektiologie und Pneumologie, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin. stefan.hippenstiel@charite.de

Der Internist
|April 13, 2007
PubMed

Insights

Pneumonia critically impairs lung gas exchange due to diverse pathogens and overwhelming inflammation. Therapeutic strategies should enhance antimicrobial defenses while limiting inflammation for better outcomes.

Area of Science:

  • Pulmonary immunology
  • Infectious disease pathology
  • Innate immune response

Context:

  • Pneumonia causes severe lung gas exchange impairment.
  • Pathogen virulence factors and host immune responses critically influence disease severity.
  • Overwhelming inflammation can lead to lung barrier failure.

Purpose:

  • To elucidate the mechanisms of pulmonary immune defense against pneumonia pathogens.
  • To understand the role of receptor-mediated innate immunity in pneumonia.
  • To identify therapeutic targets for managing pneumonia-induced inflammation and gas exchange impairment.

Summary:

  • Pneumonia involves diverse pathogens and virulence factors impacting lung function.
  • Host innate immunity, involving transmembranous and cytosolic receptors, detects pathogens.
  • Inflammatory responses, while crucial, can cause lung damage and gas exchange failure.

Impact:

  • Highlights the dual role of inflammation in host defense and pathology.
  • Suggests therapeutic strategies should balance antimicrobial enhancement with inflammation control.
  • Informs the development of novel treatments for pneumonia beyond traditional antibiotics.

More Related Videos

Experimental Model to Evaluate Resolution of Pneumonia09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation